Navigation Links
EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR,Annual Meeting

tubule destabilizing agent) sensitive and resistant leukemia cell lines. Results from in vivo studies also showed that treatment with ENMD-1198 prolonged survival rates significantly in vinca alkaloid sensitive and resistant (ALL3, ALL7 and ALL19) preclinical leukemia models.

"These data further support ENMD-1198's potential for broad application in a variety of solid and hematological cancers," said Carolyn F. Sidor, M.D., M.B.A., EntreMed's Vice President and Chief Medical Officer. "Preclinical studies with ENMD-1198 continue to highlight its significant antitumor activity and multiple mechanisms of action. These studies will help guide our selection of indications for further clinical development. ENMD-1198 is currently in a Phase 1 dose-escalation study in advanced cancer patients, and we anticipate presentation of interim clinical data from the Phase 1 study later this year."

To view the poster presentations, visit Scientific Presentations under the Therapeutic Pathways section of the Company's web site at http://www.entremed.com.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R) (2-methoxyestradiol or 2ME2), the Company's lead drug candidate, is currently in Phase 2 clinical trials for cancer, as well as in preclinical development for rheumatoid arthritis. MKC-1, an oral cell cycle regulator, is in Phase 2 studies for cancer. ENMD-1198, a novel tubulin binding agent, is also in Phase 1 studies in advanced cancers. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's website at '"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
5. EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
6. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
10. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
11. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
Post Your Comments:
(Date:12/19/2014)... LAKE FOREST, Ill. , Dec. 19, 2014 /PRNewswire/ ... the world,s leading provider of injectable drugs and infusion ... the J.P. Morgan 33rd Annual Healthcare Conference on Wednesday, ... The presentation is scheduled to begin at 10:30 ... will be available to all interested parties through a ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
(Date:12/19/2014)... Dec. 18, 2014  Sage Analytics ( www.sageanalytics.com ... equipment for the testing of marijuana potency and ... new Luminary™ Profiler, the industry,s first product suite ... a cost-effective, portable unit. Designed from ... of the cannabis industry, the Luminary™ Profiler utilizes ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
(Date:12/19/2014)... Tampa, FL (PRWEB) December 19, 2014 ... Celliant Revitalizing Bedsheets are now available. Celliant, the ... in both sheets and pillowcases. , There are ... clinically proven additional circulation, increased oxygenation and balanced ... quality, faster healing and pain relief; enhanced athletic ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Silver Dollar ... official world record -- for the first time ever, Silver ... record book, Guinness World Records 2015, listing the park’s wood ... Roller Coaster. In additional awards announced this week, Silver Dollar ... Christmas Lights in the US,” USA Today’s 10Best awards for ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles ... state’s largest lake with more than 600 miles of ... a little more than 3,000 residents, hosted its annual ... 6th of December. , Featuring Santa, Christmas lights and ... on Main Street. Narconon Arrowhead’s parade float participated ...
(Date:12/19/2014)... (PRWEB) December 20, 2014 An evening dress ... in a lady’s closet. Discount-Dress.com, a distinguished dresses retailer, has ... buy beautiful dresses in this great shopping platform. Customers ... to the staff's hard work, Discount-Dress.com has been accepted and ... a faster and easier shopping stage for clients. In order ...
(Date:12/19/2014)... 20, 2014 The print component of ... Business subscription of the Toronto Star, with a circulation ... 622,169. The digital component is distributed nationally through a ... top news sites and partner outlets. To explore the ... , The publication features an exclusive interview with ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... of existing cancer drugs? A preclinical study presented// at ... Therapeutics, in Prague, Czech Republic concluded that the answer ... treatment options for patients suffering from non-small cell lung ... form in the tissues of the lung. ...
... Toronto, Canada have found that only a small portion of ... the cells as believed earlier. // ,This is the ... found to be the source of the disease. Previously it ... supports the view - stem cells may be responsible for ...
... survey reveals that majority of doctors' fail in recognizing cow's ... in five GPs are not able to correctly diagnose the ... a risk to long-term health. ,The survey of ... Against Allergy and is sponsored by SHS International. The survey ...
... provincial livestock authorities to ensure all poultry farms are sanitized, ... left an indelible loss to the poultry industry. ... at the Department of Livestock Development confirmed that this move ... central provinces. Thailand has been free from bird flu for ...
... increasing numbers of childhood cancer patients survive into adulthood, ... in treatment, say senior cancer and fertility scientists. ... New Zealand are diagnosed with cancer every year, says ... Melbourne’s Royal Children’s Hospital. ,“About 75 ...
... meet diagnostic criteria for PTSD though males experience more ... a review of 25 years of research published by ... of psychological bulletin. ,The authors reviewed 290 ... is more at risk for potentially traumatic events (PTE) ...
Cached Medicine News:Health News:Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs 2Health News:Cancer Stem Cells Alone spread Cancer 2Health News:Majority Of Doctors Tend To Ignore Milk Allergy Cases In Babies 2Health News:Preserving Fertility for Child Cancer Patients 2Health News:Women Are More At Risk For PTSD Than Men 2Health News:Women Are More At Risk For PTSD Than Men 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: